Respiratory Pathogen Testing Market

Global Respiratory Pathogen Testing Market: Overview

The growth of the global respiratory pathogen testing market is estimated to be driven by the continuously rising incidence of respiratory diseases. There are several factors that contribute toward the growing incidence of respiratory illnesses of which escalation in the level of pollution is the primary one. According to centers for disease control and prevention (CDC), one of the leading causes of death across the globe, rather the third main cause of death in the US is chronic obstructive pulmonary disease (COPD). Such high occurrences of the disease are estimated to multiply the opportunity of growth for the global respiratory pathogen testing market over the tenure of analysis, from 2020 to 2030.

Type, application, and region are the three important parameters based on which the global respiratory pathogen testing market has been classified. Such detailed analysis of the market comes with the sole purpose to provide stakeholders with a detailed and clear analysis of the global respiratory pathogen testing market.

Global Respiratory Pathogen Testing Market: Notable Developments

One of the important market developments that give a quick view of the dynamics pertaining to the global respiratory pathogen testing market is mentioned as below:

• In December 2019, The National Institute of Allergy and Infectious Diseases (NIAID) declared the setting up of Infectious Diseases Clinical Research Consortium. This consortium is a network of clinical trials, which comprises the vaccine and treatment evaluation units (VTEUs) of the institute.  The institute plans to make an investment of around US$ 29 Mn every year for the next seven years. This program is likely to fuel development of procedures of respiratory pathogen testing.

Some of the prominent organizations in the global respiratory pathogen testing market comprise the below-mentioned:

• Becton, Dickinson and Company (BD)
• Koninklijke Philips N.V.
• MGC Diagnostics Corporation and Subsidiaries
• CAREstream Medical Ltd
• Fisher & Paykel Healthcare
• ResMed Company

Global Respiratory Pathogen Testing Market: Key Trends

The global respiratory pathogen testing market is characterized by the presence of the following restraints, drivers, and opportunities.

Integration of Advanced Technologies with the Diagnosis Procedures to Bolster Demand

Integration of latest technologies in the diagnosis of chronic obstructive pulmonary disease (COPD) s likely to play an important role in the growth of the global respiratory pathogen testing market over the forecast period, from 2020 to 2030. Adoption of imaging technologies like computed tomography (CT) is considered important in the diagnosis of respiratory diseases.

Utilization of various technically progressive devices such as pulse oximeters for the purpose of efficacious management of COPD in outpatients is rapidly gaining acceptance and popularity. In addition, a shift toward utilization of noninvasive mechanical ventilation for cases of COPD is likely to trigger growth of the global respiratory pathogen testing market in the years to come.

The development of the global respiratory pathogen testing market is likely to be shaped by the rapid spread of various types of infections, such as hospital acquired infection and tuberculosis. In case of such infectious diseases, respiratory pathogen testing is required in the form of a preliminary detection tool. 

Global Respiratory Pathogen Testing Market: Geographical Analysis

The global respiratory pathogen testing market is likely to be dominated by two regions, North America and Europe. Both the regions are estimated to account for a sizeable chunk of the market over the period of analysis, from 2020 to 2030. In addition to the high prevalence of infectious diseases like Covid-19 in these regions, sedentary lifestyle is also estimated to play an important role in the growth of the market in the regions.